Garadacimab (Anti-F12 / Factor XII)
Garadacimab (Anti-F12 / Factor XII) (A2503-GRP)
Products
Description
Garadacimab (Anti-F12 / Factor XII) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research. MW: 145.5 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2503 |